The burden of prostate cancer in Canada

Authors

  • Yves Fradet Professor of Surgery/Urology, Department of Urology, Laval University, Quebec, QC
  • Laurence Klotz Professor, Department of Surgery, University of Toronto, Toronto, ON
  • John Trachtenberg Professor of Surgery and Medical Imaging, University of Toronto, Toronto, ON
  • Alexandre Zlotta Professor, Department of Surgery (Urology), University of Toronto, Toronto, ON

DOI:

https://doi.org/10.5489/cuaj.1113

Abstract

The clinical and economic burden of prostate cancer in Canada is substantial,
and is rising. Studies indicate that 1 in 7 men will develop prostate cancer during
their lifetime, and another 1 in 27 will die because of it. It is estimated that
4300 Canadian men will die of prostate cancer in 2008. Age, family history, race
and diet are all risks associated with the development of prostate cancer. A diagnosis
of cancer carries a significant burden and like other cancers is a cause of
significant anxiety and depression. Uncertainty regarding the value of screening
for prostate cancer has been, and continues to be, a challenge for primary
care physicians and urologists.

Downloads

Download data is not yet available.

Author Biographies

Yves Fradet, Professor of Surgery/Urology, Department of Urology, Laval University, Quebec, QC

Laurence Klotz, Professor, Department of Surgery, University of Toronto, Toronto, ON

John Trachtenberg, Professor of Surgery and Medical Imaging, University of Toronto, Toronto, ON

Alexandre Zlotta, Professor, Department of Surgery (Urology), University of Toronto, Toronto, ON

Downloads

How to Cite

Fradet, Y., Klotz, L., Trachtenberg, J., & Zlotta, A. (2013). The burden of prostate cancer in Canada. Canadian Urological Association Journal, 3(3-S2), S102-S108. https://doi.org/10.5489/cuaj.1113